Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging
NCT04943211
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Histiocytosis
Interventions
DRUG:
fluorodeoxyglucose (18F-FDG)
Sponsor
Anna Raciborska
Collaborators
[object Object]
[object Object]
[object Object]